Peripheral neuropathy encompasses diverse conditions—diabetic, idiopathic, chemotherapy-induced, ischaemic—characterised by progressive nerve fibre loss, demyelination, and sensorimotor dysfunction.
Peripheral neuropathy encompasses diverse conditions—diabetic, idiopathic, chemotherapy-induced, ischaemic—characterised by progressive nerve fibre loss, demyelination, and sensorimotor dysfunction. Stem cell therapies exploit multiple pathways: placental mesenchymal stem cells (MSCs) secrete neurotrophic factors (NGF, GDNF, VEGF) that promote nerve regeneration and angiogenesis; neurogenic cells differentiate into functional neurons to replace damaged fibres; exosomes deliver growth factor cargo directly into affected peripheral tissues. The rationale combines neuroprotection (halting further degeneration), neuroregenerative repair (sprouting of surviving axons), and vascular restoration (improving ischaemic neuropathy). Forty-six registered trials investigate efficacy across neuropathy subtypes; eight actively recruit, indicating expanding clinical capacity and commercial interest.
| Cost indicativ · Bulgaria (UE) | €3,000–€8,000 |
|---|---|
| Gama costurilor pieței globale | €2,300–€4,600 (dvcstem.com) |
| Principalele tipuri de celule studiate | MSCs from Amniotic Membrane, Neurogenic Cells, Exosomes |
| Statutul aprobării | Investigațional |
| Studii înregistrate (ClinicalTrials.gov) | 46 · 8 recruiting now |
For the clinic's own description, see our partner clinic Stem Plus.
Published trials of intra-muscular or systemic placental MSC injection report improved sensory function in 45–60% of diabetic neuropathy patients and pain reduction in 50–70% of painful neuropathy cohorts. Electrophysiological endpoints (nerve conduction velocity, F-wave latency) show modest improvement in responders. A phase II diabetic neuropathy trial (80 patients) found reduction in neuropathic pain score by 40–50% at 12 months in treated versus sham-injected groups. Neurogenic cell therapies are less extensively studied; early trials show safety signals but limited efficacy data. Exosome therapy is emerging with small proofs-of-concept suggesting reduced pain and improved sensation in chemotherapy-induced neuropathy.
Depending on assessment, a Peripheral Neuropathy protocol may draw on:
Neuropathy cell therapy costs €4,000–6,500 depending on delivery method and cell source. Systemic intravenous MSC infusion (€4,500–5,500) is most accessible. Intra-muscular or targeted intrathecal injection (€5,500–7,000) delivers higher local concentration but requires specialised placement. Exosome therapy (€4,000–5,500) is emerging with competitive pricing. Multiple infusions over 3–6 months are often recommended, doubling total cost to €8,000–13,000. Insurance rarely reimburses; out-of-pocket expense is standard globally, though some regional trials offer free or subsidised access to enrolled patients.
Indicative EU treatment cost is €3,000–€8,000 versus roughly €15,000–35,000 in the US or Germany. Build your real all-in total with the cost calculator, see the Peripheral Neuropathy cost-by-country breakdown, or compare the best countries for Peripheral Neuropathy →
Before booking, check safety & regulation, the recovery climate, dacă ai putea fi candidat, and which cell type fits Peripheral Neuropathy.
FAQ complet Neuropatie Periferică → · Defalcare costuri Neuropatie Periferică →
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
Useful tools & guides: Sunt eu un candidat? · Ce tip de celulă? · Types of clinics & best countries · Calculator de costuri
Revizuit medical de echipa editorială a StemCellAtlas cu Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) ale clinicii partenere Stem Plus (Sofia), în funcție de orientările ISSCR, FDA și EMA. Educational information, not medical advice; figures indicative.
Medicină regenerativă certificată GMP în inima UE — de la 3.000–8.000 €, o fracțiune din prețurile din SUA sau Germania. Protocoale personalizate pentru pacienți din peste 50 de țări.
Evaluare medicală gratuită